Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)
نویسندگان
چکیده
منابع مشابه
Transfusion Medicine 2 Platelet transfusions
Ever since platelet transfusions were shown to reduce mortality from haemorrhage in patients with acute leukaemia in the 1950s, the use of this therapy has steadily grown to become an essential part of the treatment of cancer, haematological malignancies, marrow failure, and haematopoietic stem cell transplantation. Today, more than 1·5 million platelet products are transfused in the USA each y...
متن کاملTransfusion malaria in sick neonates.
Malaria is an uncommon illness during the neonatal period and early infancy. Transplacental barrier, presence of acquired immunity from the mother (in endemic malarious region) and preponderance of fetal hemoglobin are some of the reasons for this observations(l). Post-transfusion malaria is a possibility not only after whole blood transfusion, but also after infusion of components such as plat...
متن کاملThrombocytopenia, bleeding, and use of platelet transfusions in sick neonates.
Survival rates for infants born prematurely have improved significantly, in part due to better supportive care such as RBC transfusion. The role of platelet transfusions in neonates is more controversial. Neonatal thrombocytopenia is common in premature infants. The primary causal factors are intrauterine growth restriction/maternal hypertension, in which the infant presents with thrombocytopen...
متن کاملHow we decide when a neonate needs a transfusion.
The decision to transfuse a neonate can be approached by addressing a series of questions that cover the cause of anaemia, alternatives to transfusion, the need for transfusion and the risks. Recent clinical trials of red cell transfusions have started to inform evidence-based transfusion practice, but have raised uncertainties about neurological outcomes when policies advocating use of fewer r...
متن کاملEvaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.
Prophylactic platelet transfusion reduces the risk of hemorrhage in patients undergoing chemotherapy for leukemia, and platelet transfusions have been given when the platelet count falls below 20,000/μL (1). Recently, several clinical trials have demonstrated that for prophylactic platelet transfusions, the platelet trigger value of 10,000/μL is superior to that of 20,000/μL in terms of safety ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Transfusion Medicine
سال: 2019
ISSN: 0958-7578
DOI: 10.1111/tme.12587